Alnylam Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. 

CEO
Yvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees
2,230
Employees2,230
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2002
Founded2002
Employees
2,230
Employees2,230

ALNY Key Statistics

Market cap
61.65B
Market cap61.65B
Price-Earnings ratio
-190.62
Price-Earnings ratio-190.62
Dividend yield
Dividend yield
Average volume
1.14M
Average volume1.14M
High today
$485.28
High today$485.28
Low today
$467.50
Low today$467.50
Open price
$469.19
Open price$469.19
Volume
1.44M
Volume1.44M
52 Week high
$485.28
52 Week high$485.28
52 Week low
$205.87
52 Week low$205.87

ALNY News

Simply Wall St 4d
Alnylam Pharmaceuticals: Valuation Snapshot Following New Phase 3 Data and Pipeline Progress

Alnylam Pharmaceuticals (ALNY) has caught investor attention after announcing progress on two key fronts. The company has initiated the Phase 3 ZENITH study for...

Alnylam Pharmaceuticals: Valuation Snapshot Following New Phase 3 Data and Pipeline Progress
TipRanks 7d
Alnylam and Regeneron Join Forces in Promising Alzheimer’s Study

Alnylam Pharmaceuticals ((ALNY)), Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take...

Analyst ratings

74%

of 31 ratings
Buy
74.2%
Hold
22.6%
Sell
3.2%

People also own

Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.